Maldonado, S.; Fuentes, P.; Bernabeu, E.; Bertera, F.; Opezzo, J.; Lagomarsino, E.; Lee, H.J.; MartÃnez RodrÃguez, F.; Choi, M.R.; Salgueiro, M.J.;
et al. Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses. Pharmaceutics 2025, 17, 241.
https://doi.org/10.3390/pharmaceutics17020241
AMA Style
Maldonado S, Fuentes P, Bernabeu E, Bertera F, Opezzo J, Lagomarsino E, Lee HJ, MartÃnez RodrÃguez F, Choi MR, Salgueiro MJ,
et al. Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses. Pharmaceutics. 2025; 17(2):241.
https://doi.org/10.3390/pharmaceutics17020241
Chicago/Turabian Style
Maldonado, SofÃa, Pedro Fuentes, Ezequiel Bernabeu, Facundo Bertera, Javier Opezzo, Eduardo Lagomarsino, Hyun J. Lee, Fleming MartÃnez RodrÃguez, Marcelo R. Choi, MarÃa Jimena Salgueiro,
and et al. 2025. "Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses" Pharmaceutics 17, no. 2: 241.
https://doi.org/10.3390/pharmaceutics17020241
APA Style
Maldonado, S., Fuentes, P., Bernabeu, E., Bertera, F., Opezzo, J., Lagomarsino, E., Lee, H. J., MartÃnez RodrÃguez, F., Choi, M. R., Salgueiro, M. J., Damonte, E. B., Höcht, C., Moretton, M. A., Sepúlveda, C. S., & Chiappetta, D. A.
(2025). Efavirenz Repurposing Challenges: A Novel Nanomicelle-Based Antiviral Therapy Against Mosquito-Borne Flaviviruses. Pharmaceutics, 17(2), 241.
https://doi.org/10.3390/pharmaceutics17020241
